Favipiravir (T-705) protects against peracute Rift Valley fever virus infection and reduces delayed-onset neurologic disease observed with ribavirin treatment
Autor: | Scharton, Dionna, Bailey, Kevin W., Vest, Zachary, Westover, Jonna B., Kumaki, Yohichi, Van Wettere, Arnaud, Furuta, Yousuke, Gowen, Brian B. |
---|---|
Zdroj: | In Antiviral Research April 2014 104:84-92 |
Databáze: | ScienceDirect |
Externí odkaz: |